In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy
Cancers · 09.12.2023 · 15 (24) · 5779
DOI: 10.3390/cancers15245779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 09.12.2023. Verfasst von Gemma Nomdedeu-Sancho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Wake Forest Institute for Regenerative Medicine.
Abstract (Originalsprache)
Melanoma is responsible for the majority of skin cancer-related fatalities. Immune checkpoint inhibitor (ICI) treatments have revolutionized the management of the disease by significantly increasing patient survival rates. However, a considerable number of tumors treated with these drugs fail to respond or may develop resistance over time. Tumor growth and its response to therapies are critically influenced by the tumor microenvironment (TME); it directly supports cancer cell growth and influences the behavior of surrounding immune cells, which can become tumor-permissive, thereby rendering immunotherapies ineffective. Ex vivo modeling of melanomas and their response to treatment could significantly advance our understanding and predictions of therapy outcomes. Efforts have been directed toward developing reliable models that accurately mimic melanoma in its appropriate tissue environment, including tumor organoids, bioprinted tissue constructs, and microfluidic devices. However, incorporating and modeling the melanoma TME and immune component remains a significant challenge. Here, we review recent literature regarding the generation of in vitro 3D models of normal skin and melanoma and the approaches used to incorporate the immune compartment in such models. We discuss how these constructs could be combined and used to test immunotherapies and elucidate treatment resistance mechanisms. The development of 3D in vitro melanoma models that faithfully replicate the complexity of the TME and its interaction with the immune system will provide us with the technical tools to better understand ICI resistance and increase its efficacy, thereby improving personalized melanoma therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA.
- Wake Forest Organoid Research Center (WFORCE), Winston-Salem, NC 27101, USA.
- Pathology Section, Comparative Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA.
- Department of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27101, USA.
- Department of Surgery, Division of Surgical Oncology, Wake Forest Baptist Health, Winston Salem, NC 27157, USA.
- Medical Center Boulevard, Winston-Salem, NC 27157, USA.
ORCID-Profile: Gemma Nomdedeu-Sancho, Anthony Atala
Förderung
- NCI NIH HHS
- NIH HHS
- Wake Forest Institute for Regenerative Medicine
- Wake Forest Comprehensive Cancer Center
Zitieren
APA
Nomdedeu-Sancho, G., Gorkun, A., Mahajan, N., Willson, K., Schaaf, C. R., Votanopoulos, K. I., Atala, A., & Soker, S. (2023). In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy. Cancers, 15(24), 5779. https://doi.org/10.3390/cancers15245779
Vancouver
Nomdedeu-Sancho G, Gorkun A, Mahajan N, Willson K, Schaaf CR, Votanopoulos KI, et al. In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy. Cancers. 2023;15(24):5779. doi:10.3390/cancers15245779
BibTeX
@article{NomdedeuSancho2023,
author = {Nomdedeu-Sancho, Gemma and Gorkun, Anastasiya and Mahajan, Naresh and Willson, Kelsey and Schaaf, Cecilia R and Votanopoulos, Konstantinos I and Atala, Anthony and Soker, Shay},
title = {In Vitro Three-Dimensional (3D) Models for Melanoma Immunotherapy},
journal = {Cancers},
year = {2023},
volume = {15},
number = {24},
pages = {5779},
doi = {10.3390/cancers15245779}
}
EUVIMED